Insulet Corporation Announces Pricing of Secondary Publi... ( BEDFORD Mass. Nov. 7 /- Insulet C...)

Insulet Corporation Announces Pricing of Secondary Public Offering

Date:11/7/2007

BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation, (Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) Insulin Management System, today announced the pricing of its public offering of 4,898,398 shares of common stock at $23.25 per share, all of which are being sold by selling stockholders. Insulet will not receive any proceeds from the sale of shares by the selling stockholders. Insulet has granted to the underwriters an option to purchase up to 734,759 shares of its common stock at the public offering price to cover any over-allotments.

J.P. Morgan Securities Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated are acting as joint book-running managers, and Leerink Swann LLC, Thomas Weisel Partners LLC and Canaccord Adams Inc. are acting as co-managers for the offering.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and has become effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offer or sale will be made only by means of the written prospectus forming part of the effective registration statement.

A copy of the prospectus relating to the offering may be obtained by contacting one of the following:

J.P. Morgan Securities Inc., National Statement Processing, Prospectus

Library, 4 Chase Metrotech Center, CS Level, Brooklyn, NY 11245 or by

calling (718) 242-8002.

Merrill Lynch, Pier
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. Insulet Awarded National Accreditation for Excellence by Community Health Accreditation Program
2. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
3. Brooke Franchise Corporation Announces Selected July Results
4. MedThink Communications Retained by NanoBio Corporation
5. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
6. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
7. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
8. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer

Post Your Comments:

Insulet Corporation Announces Pricing of Secondary Publi...( BEDFORD Mass. Nov. 7 /- Insulet C...),Health